Who are Aardvark Therapeutics, Inc.'s main suppliers?

Aardvark Therapeutics, Inc. (AARD) key suppliers include: PIPER-SANDLER-CO, Scilex Holding Company. View the full supplier network at chainsifter.com/chain/AARD.

Who are Aardvark Therapeutics, Inc.'s major customers?

Aardvark Therapeutics, Inc. (AARD) key customers include: Bright Minds Biosciences Inc., Bright Minds Biosciences Inc., Neurocrine Biosciences, Inc., Neurocrine Biosciences, Inc.. View the full customer network at chainsifter.com/chain/AARD.

What sector is Aardvark Therapeutics, Inc. in?

Aardvark Therapeutics, Inc. (AARD) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Aardvark Therapeutics, Inc. (AARD): 8 Verified Supply Chain Relationships

2Suppliers

4Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Aardvark Therapeutics, Inc. (AARD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships

3Distinct source URLs

4High confidence

0.800Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Aardvark Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
PIPER-SANDLER-CO	PIPER-SANDLER-CO	90%	The Company has agreed in the Equity Distribution Agreement to provide indemnification and contribution to the Agent against certain liabilities, including liabilities under the Securities Act of 193…
SCLX	Scilex Holding Company	72%	Reciprocal relationship from SCLX graph: ement with EAR SPV LLC, a Delaware corporation (“EAR SPV”) and Vivasor Holding Company (“VHC”), a privately held biotechnology company, pursuant to which, amo…

Aardvark Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
DRUG	Bright Minds Biosciences Inc.	72%	Reciprocal relationship from DRUG graph: Reciprocal relationship from AARD graph: , operating results, prospects or financial condition. Risks Related to Artificial Intelligence We may use certain ar…
DRUG	Bright Minds Biosciences Inc.	72%	, operating results, prospects or financial condition. Risks Related to Artificial Intelligence We may use certain artificial intelligence (AI) technologies, which present risks and challenges that c…
NBIX	Neurocrine Biosciences, Inc.	72%	Reciprocal relationship from NBIX graph: Reciprocal relationship from AARD graph: Reciprocal relationship from NBIX graph: Reciprocal relationship from AARD graph: , operating results, prospects or f…
NBIX	Neurocrine Biosciences, Inc.	72%	, operating results, prospects or financial condition. Risks Related to Artificial Intelligence We may use certain artificial intelligence (AI) technologies, which present risks and challenges that c…

Aardvark Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
AARD-DEBT	Debt stack $336,000	90%	Market cache reports total debt of $336,000.
AARD-DEBT-7408	Xbrl Convertible	90%	xbrl convertible event from 2025-12-31.

Aardvark Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Aardvark Therapeutics, Inc..

Aardvark Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
AARD-OWNER-DECHENG-CAPITAL-LLC	Decheng Capital LLC	90%	13F overlay lists Decheng Capital LLC as top holder; 80 tracked holders.

Aardvark Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
DRUG	Bright Minds Biosciences Inc.	100.00	1	['customer']
NBIX	Neurocrine Biosciences, Inc.	100.00	1	['customer']
SCLX	Scilex Holding Company	100.00	1	['supplier']
ORANY	ORANGE	50.00	2
SMNRW	Semnur Pharmaceuticals, Inc.	50.00	2
A	Agilent Technologies, Inc.	50.00	2
COLL	Collegium Pharmaceutical, Inc.	50.00	2
BMY	Bristol-Myers Squibb Company	50.00	2
BMYMP	Bristol-Myers Squibb Co	50.00	2
TKPHF	Takeda Pharmaceutical Company Limited	50.00	2
SPRB	Spruce Biosciences, Inc.	50.00	2
ORMP	Oramed Pharmaceuticals Inc.	50.00	2
STQN	Strategic Acquisitions, Inc.	50.00	2
SMNR	Semnur Pharmaceuticals, Inc.	50.00	2
SLNO	Soleno Therapeutics, Inc.	50.00	2
MPLT	MapLight Therapeutics, Inc.	50.00	2
SNYNF	Sanofi	50.00	2
ITOCHU	ITOCHU	50.00	2
DVLT	Datavault AI Inc.	50.00	2
ETON	Eton Pharmaceuticals, Inc.	50.00	2

Aardvark Therapeutics, Inc. Supply Chain